After treatment for a craniopharyngioma there are many chronic health problems to be aware of and to screen for in long-term survivors of this disease.
Here is a PDF (which can be printed) giving an example of the type of follow up necessary for a long-term survivor after treatment for craniopharyngioma:
Example of annual follow up:
Investigation |
Important aspects: |
History |
- Level of energy, general health
- Vision
- Neurological symptoms (for example headaches, seizures and TIA type episodes)
- Change in short term memory
- Depression
- Social/employment situation
- Smoking, alcohol ingestion and recreational drug use
- Current medications
- List of physicians/HCPs involved in follow up
|
Examination |
Always Check:
|
Neurocognitive testing |
- If there are problems such as short term memory loss, it may be important to formally document cognitive impairment in order to obtain vocational or recreational rehab & to apply or a disability pension
|
Blood work |
|
Radiology screening |
|
Specialist
follow-up |
Assessment by the following specialists every year:
- Endocrinology
- Ophthalmology or Neuro-ophthalmology
|
Supportive care |
- Family counselling
- Psychology
- Psychiatry
- Vocational and recreational rehab
|
Advice |
Lifestyle:
- Advise about diet, exercise and lifestyle choices (such as smoking) which may further increase the risk of vascular disease
- Avoid sunburn and wear a hat to protect skin and scalp from sun related damage
|
ACTH Deficiency:
- During infection, surgery and illness craniopharyngioma survivors are very likely to need support with extra steroid medication
- Medic Alert bracelets are advised to warn about ACTH deficiency
|
Second malignant
neoplasms (SMNs):
The patient should be advised to seek immediate medical
help if:
- A new swelling (painless or painful) appears within the previous RT field as
this may be due to a SMN
- Severe, persistent headaches develop associated with possible nausea and
vomiting (may be associated with a new intracranial mass lesion)
|
Patient Information at Children's Oncology Group long term follow up guidelines: |
|